Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2015 1
2016 1
2017 3
2018 3
2019 1
2020 6
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer.
Oliveira ALCSL, Zerillo L, Cruz LJ, Schomann T, Chan AB, de Carvalho TG, Souza SVP, Araújo AA, de Geus-Oei LF, de Araújo Júnior RF. Oliveira ALCSL, et al. Among authors: chan ab. Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111678. doi: 10.1016/j.msec.2020.111678. Epub 2020 Oct 27. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33545840 Free article.
Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin's Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer.
Jorquera-Cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Jorquera-Cordero C, et al. Among authors: chan ab. Pharmaceutics. 2022 May 17;14(5):1068. doi: 10.3390/pharmaceutics14051068. Pharmaceutics. 2022. PMID: 35631654 Free PMC article.
Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer.
Júnior RFA, Lira GA, Schomann T, Cavalcante RS, Vilar NF, de Paula RCM, Gomes RF, Chung CK, Jorquera-Cordero C, Vepris O, Chan AB, Cruz LJ. Júnior RFA, et al. Among authors: chan ab. Transl Oncol. 2023 May;31:101647. doi: 10.1016/j.tranon.2023.101647. Epub 2023 Feb 27. Transl Oncol. 2023. PMID: 36857852 Free PMC article.
STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer.
Cavalcante RS, Ishikawa U, Silva ES, Silva-Júnior AA, Araújo AA, Cruz LJ, Chan AB, de Araújo Júnior RF. Cavalcante RS, et al. Among authors: chan ab. Br J Pharmacol. 2021 Jun;178(11):2284-2304. doi: 10.1111/bph.15373. Epub 2021 Mar 31. Br J Pharmacol. 2021. PMID: 33434950 Free PMC article.
AT1 and AT2 Receptor Knockout Changed Osteonectin and Bone Density in Mice in Periodontal Inflammation Experimental Model.
Lima MLS, Medeiros CACX, Guerra GCB, Santos R, Bader M, Pirih FQ, Araújo Júnior RF, Chan AB, Cruz LJ, Brito GAC, Leitão RFC, Silveira EJDD, Garcia VB, Martins AA, Araújo AA. Lima MLS, et al. Among authors: chan ab. Int J Mol Sci. 2021 May 14;22(10):5217. doi: 10.3390/ijms22105217. Int J Mol Sci. 2021. PMID: 34069164 Free PMC article.
20 results